Application of thymidine kinase 1 and circulating tumor cell in malignant solid tumor / 中国医师杂志

Thymidine kinase 1 (TK1) is associated with the occurrence of early malignant tumor,tumor metastasis,recurrence,and the changes of TK1 in the treatment can also reflect the sensitivity of tumor to treatment.Circulating tumor cells (CTC) are removed from the primary tumor or metastatic tumor to blood.The appearance of CTC in malignant tumors is usually related to the poor prognosis,such as metastasis and recurrence,short survival time and so on.The combination of TK1 and CTC can also be used as an independent predictor of survival.Now we analyse and summarize the role of TK1 and CTC in tumorigenesis and development.

Application of thymidine kinase 1 and circulating tumor cell in malignant solid tumor / 中国医师杂志

Thymidine kinase 1 (TK1) is associated with the occurrence of early malignant tumor, tumor metastasis, recurrence, and the changes of TK1 in the treatment can also reflect the sensitivity of tumor to treatment. Circulating tumor cells (CTC) are removed from the primary tumor or metastatic tumor to blood. The appearance of CTC in malignant tumors is usually related to the poor prognosis, such as metastasis and recurrence, short survival time and so on. The combination of TK1 and CTC can also be used as an independent predictor of survival. Now we analyse and summarize the role of TK1 and CTC in tumorigenesis and development .